Biovica International AB (publ) announces that Anders Morén has been appointed as the company's Chief Financial Officer (CFO). Anders Morén will begin his new position on January 1, 2023. Most recently, Anders Morén comes from the global pharmaceutical company Gilead where he was responsible for the finance function for a large part of Europe, Middle East and Africa (EMEA, with over SEK 10 billion in annual sales).

Anders Morén succeeds Cecilia Driving, who, as previously announced, is leaving Biovica on December 31, 2022.